Merck, Ridgeback Biotherapeutics withdraw COVID pill Molnupiravir application in EU Ruchika Sharma30 Jun 2023 10:00 AM ISTMerck and Co and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union,...
Merck beats first-quarter expectations on Keytruda, Gardasil strength Ruchika Sharma30 April 2023 4:00 PM ISTBengaluru: Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster...
EU drug regulator advices against market nod for Merck COVID pill Lagevrio for adults Ruchika Sharma26 Feb 2023 3:45 PM ISTUS: The European Union's drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of...
USFDA removes COVID test requirements for Merck, Pfizer pills Ruchika Sharma2 Feb 2023 12:15 PM ISTThe health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID...
Merck, Ridgeback Molnupiravir gets special approval for emergency in Japan Ruchika Sharma25 Dec 2021 2:46 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan's Ministry of Health,...
Narrow Vote but Merck's molnupiravir gets USFDA expert panel Yes Ruchika Sharma1 Dec 2021 12:08 PM ISTThe vote was 13 for and 10 against authorization
